Abstract
The use of fluoroquinolone is contraindicated in children because of the potential complication of arthropathy. In spite of this, the role of ciprofloxacin is becoming increasingly significant. We report two cases in which organisms that did not respond to the use of some other potent antibiotics clearly responded to the use of ciprofloxacin. A general overview of the fluoroquinolones is also highlighted. It is concluded that ciprofloxacin is a very useful agent in the management of serious infections in children and available data clearly supports its use where the efficacy outweighs any considerable risk. Fluoroquinolone is therefore recommended in children where it offers a clear therapeutic advantage over other classes of antibiotics but not for routine empirical use.African Journal of Clinical and Experimental Microbiology Vol. 7(2) 2006: 132-135
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: African Journal of Clinical and Experimental Microbiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
